SEC Form 3 · accession 0001104659-17-060876
RHYTHM PHARMACEUTICALS, INC. · RYTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred T. Fiedorek
Officer — Chief Medical Officer
Period of report
Oct 4, 2017
Accepted (ET)
Oct 4, 2017 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649904
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 131,899 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $4.59 | holding | — | — | — | — | Nov 16, 2025 | Common Stock | 79,816 | — | D |
| Employee Stock Option (Right to Buy)F2 | $7.52 | holding | — | — | — | — | Dec 30, 2025 | Common Stock | 9,814 | — | D |
| Employee Stock Option (Right to Buy)F3 | $6.14 | holding | — | — | — | — | Apr 4, 2027 | Common Stock | 10,905 | — | D |
Explanation of responses
- F1The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015.
- F2The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015.
- F3The stock options vest and become exercisable in 48 successive, equal monthly installments measured from January 6, 2017.
Remarks
Exhibit List Exhibit 24 - Power of Attorney